874 resultados para [37:2]


Relevância:

100.00% 100.00%

Publicador:

Relevância:

100.00% 100.00%

Publicador:

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Recurso electrónico. Valencia: BVNP, 2014

Relevância:

100.00% 100.00%

Publicador:

Relevância:

100.00% 100.00%

Publicador:

Resumo:

The JOIDES Pacific Advisory Panel proposed Site 37 to meet two principal objectives: to determine the significance of the magnetic anomaly pattern, and the longitudinal profile of the sediment sequence in the eastern Pacific. Site 37 was to be located on the same magnetic anomaly as was Site 33 (#10, 32 million years age), for comparison across the intervening Mendocino Fracture Zone. As basement had not been reached at Site 33, this objective could not be met specifically. However, sediment comparison across the fracture zone was possible.

Relevância:

70.00% 70.00%

Publicador:

Resumo:

结果显示 :当年草鱼种和中华鳖脾细胞培养上清液中能检测出IL 2活性 ,而且 1龄以上草鱼、中华鳖的IL 2活性高于当年孵化的草鱼和中华鳖。草鱼、中华鳖脾细胞在 2 5℃培养温度条件下 ,其上清液中IL 2活性最高 ,35℃次之 ,1 5℃最低。因此 ,草鱼、中华鳖IL 2活性在一定范围内是随着年龄增加而增强和依赖温度的。通过小鼠胸腺细胞增殖和对小鼠L92 9细胞杀伤率的实验表明 37℃比 2 5℃检测温度下所测的IL 2活性高 ,而中华鳖胸腺细胞增殖实验却显示 2 5℃检测温度下IL 2活性高于 37

Relevância:

70.00% 70.00%

Publicador:

Resumo:

Seasonal cycles in the rates of oxygen consumption, feeding, absorption efficiency and ammonia-nitrogen excretion in two populations of Mytilus edulis were measured in the field under ambient conditions and related to body size, the gametogenic cycle, the concentration of suspended particulate matter in the water and temperature. Relationships between the various physiological variables are also considered and protein and energy budgets estimated. Both the “scope for growth” and the “relative maintenance cost” were seasonally variable, demonstrating a minimum capacity for growth in the winter and a maximum capacity in the summer. In one population subjected to abnormally high temperatures in the winter the scope for growth was negative for four or five months between January and May. These population differences are discussed and the potential for using physiological integrations in intra-specific comparisons of fitness is identified.

Relevância:

70.00% 70.00%

Publicador:

Resumo:

Comprend : Pensées de Montesquieu adressées à son fils, tirées d'un manuscrit que l'on dit être original ; Madrigal et épigramme sur la Troade de Pradon

Relevância:

70.00% 70.00%

Publicador:

Resumo:

AIMS To assess incidence rates (IRs) of and identify risk factors for incident severe hypoglycaemia in patients with type 2 diabetes newly treated with antidiabetic drugs. METHODS Using the UK-based General Practice Research Database, we performed a retrospective cohort study between 1994 and 2011 and a nested case-control analysis. Ten controls from the population at risk were matched to each case with a recorded severe hypoglycaemia during follow-up on general practice, years of history in the database and calendar time. Using multivariate conditional logistic regression analyses, we adjusted for potential confounders. RESULTS Of 130,761 patients with newly treated type 2 diabetes (mean age 61.7 ± 13.0 years), 690 (0.5%) had an incident episode of severe hypoglycaemia recorded [estimated IR 11.97 (95% confidence interval, CI, 11.11-12.90) per 10,000 person-years (PYs)]. The IR was markedly higher in insulin users [49.64 (95% CI, 44.08-55.89) per 10,000 PYs] than in patients not using insulin [8.03 (95% CI, 7.30-8.84) per 10,000 PYs]. Based on results of the nested case-control analysis increasing age [≥ 75 vs. 20-59 years; adjusted odds ratio (OR), 2.27; 95% CI, 1.65-3.12], cognitive impairment/dementia (adjusted OR, 2.00; 95% CI, 1.37-2.91), renal failure (adjusted OR, 1.34; 95% CI, 1.04-1.71), current use of sulphonylureas (adjusted OR, 4.45; 95% CI, 3.53-5.60) and current insulin use (adjusted OR, 11.83; 95% CI, 9.00-15.54) were all associated with an increased risk of severe hypoglycaemia. CONCLUSIONS Severe hypoglycaemia was recorded in 12 cases per 10,000 PYs. Risk factors for severe hypoglycaemia included increasing age, renal failure, cognitive impairment/dementia, and current use of insulin or sulphonylureas.